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ABSTRACT
Introduction Associations of pre- pregnancy impaired 
fasting glucose (IFG) and body mass index (BMI) with large 
for gestational age (LGA) and preterm birth (PTB) have been 
poorly understood. We aimed to investigate the associations 
of maternal BMI, separately and together with pre- pregnancy 
IFG, with LGA and PTB in Chinese population. We also aimed 
to quantify these associations by maternal age.
Research design and methods This was a retrospective 
cohort study of women from the National Free Preconception 
Health Examination Project with singleton birth from 121 
counties/districts in 21 cities of Guangdong Province, China, 
from January 1, 2013 to December 31, 2017. Women were 
included if they did not have pre- existing chronic diseases 
(diabetes, hypertension, etc). Participants were divided 
into eight groups according to their BMI (underweight 
(BMI <18.5 kg/m2), normal weight (18.5–23.9 kg/m2), 
overweight (24.0–27.9 kg/m2), and obesity (≥28.0 kg/m2)) 
and pre- pregnancy fasting glucose status (normoglycemia 
(fasting glucose concentration <6.1 mmol/L) and IFG (6.1–
7.0 mmol/L)). Adjusted incidence risk ratios (aIRRs) and 95% 
CIs of LGA, severe LGA, PTB and early PTB were estimated.
Results We included 634 030 women. The incidences of 
LGA, severe LGA, PTB and early PTB for the study population 
were 7.1%, 2.5%, 5.1% and 1.1%, respectively. Compared 
with normal weight mothers with normoglycemia, overweight 
and obese mothers irrespective of IFG had a higher risk of 
LGA (eg, obesity with IFG aIRR 1.85 (1.60–2.14)) and severe 
LGA (eg, obesity with IFG 2.19 (1.73–2.79)). The associations 
of BMI and pre- pregnancy fasting glucose status with 
LGA were similar found among women of all age groups. 
Underweight with normoglycemia had 6.0% higher risk of 
PTB (1.06 (1.03–1.09)) and 8.0% higher risk of early PTB 
(1.08 (1.02–1.17)), underweight with IFG had 14.0% higher 
risk of PTB (1.14 (1.02–1.27)), and obese mothers with 
IFG had 45.0% higher risk of PTB (1.45 (1.18–1.78)). The 
associations of BMI and pre- pregnancy fasting glucose status 
with PTB differed by maternal age.
Conclusion Overweight and obesity regardless of IFG 
were associated with an increased risk of LGA, and these 
associations were similarly observed among mothers of 
all age groups. Underweight regardless of IFG, and obesity 
with IFG were associated with an increased risk of PTB, but 
the associations differed by maternal age. Findings from 
this study may have implications for risk assessment and 
counselling before pregnancy.
INTRODUCTION
Large for gestational age (LGA) is associ-
ated with multiple risks for both the mothers 
and the neonates. Short- term risks of LGA 
Significance of this study
What is already known about this subject?
 ► Associations of pre- pregnancy impaired fasting glu-
cose (IFG) and obesity with large for gestational age 
(LGA) and preterm birth (PTB) are controversial and 
inconclusive.
 ► No study has investigated the joint associations of 
IFG and body mass index with LGA and PTB.
What are the new findings?
 ► Overweight and obesity regardless of IFG were asso-
ciated with an increased risk of LGA.
 ► Underweight regardless of IFG, and obesity with IFG 
were associated with an increased risk of PTB.
How might these results change the focus of 
research or clinical practice?
 ► This study indicates that assessing both body mass 
index and fasting glucose before pregnancy should 
be considered in further recommendations for ad-
verse pregnancy outcomes prevention.
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include an increase in intrauterine death rate, a higher 
probability of shoulder dystocia, obstetric brachial plexus 
injury and birth fractures.1 2 There are also long- term 
risks of LGA, such as obesity and chronic disease in later 
life.3 4 Preterm birth (PTB) is also a public health and 
clinical concern. It is the leading cause of death for chil-
dren below 5 years of age globally.5 PTB complications 
are estimated to be responsible for 35% of deaths among 
neonates annually, and surviving preterm neonates are 
at higher risk of respiratory and neurodevelopmental 
complications.6 Both LGA and PTB are associated with 
significant costs to health services, and families of LGA 
and PTB often experience considerable psychological 
and financial hardship.7 8 These data highlight the crit-
ical and urgent need to identify risk factors for LGA and 
PTB.
Unlike non- modifiable risk factors, such as ethnicity and 
genetic predisposition, pre- pregnancy impaired fasting 
glucose (IFG) and body mass index (BMI) are potentially 
modifiable and preventable causes of adverse pregnancy 
outcomes.9 Pre- pregnancy IFG, a status of hyperglycemia 
before conception, is associated with increased levels 
of insulin, and obesity is characteristic of elevation of 
triglyceride levels and a concomitant transient reduction 
in high- density lipoprotein levels during the pregnancy, 
both of which could contribute to the risks of LGA and 
PTB. However, the associations of pre- pregnancy IFG and 
obesity with LGA and PTB are controversial and incon-
clusive. Although pre- pregnancy IFG or obesity was a risk 
factor for LGA and PTB in some studies,10 11 in others 
null12 13 or even inverse14 associations of pre- pregnancy 
IFG and obesity with LGA and PTB were noted. In addi-
tion, there was no study which has investigated the joint 
associations of IFG and BMI with LGA and PTB.
In this study, we used data of the National Free Precon-
ception Health Examination Project (NFPHEP) from 
Guangdong Province to investigate the associations of 
pre- pregnancy IFG, alone and jointly with maternal BMI, 
with the risks of LGA and PTB. We also aimed to iden-
tify the effects of maternal age on the association of pre- 
pregnancy IFG and BMI with LGA and PTB, which are 
important to enable physicians to provide tailored advice 
and prenatal care to mothers before and during preg-
nancy, although the underlying mechanisms of maternal 
age on the associations of pre- pregnancy IFG and BMI 
with LGA and PTB have yet to be elucidated.
METHODS
Study design and population
We conducted a retrospective cohort study of women 
who participated in the NFPHEP between January 1, 
2013 and December 31, 2017, successfully became 
pregnant and then had pregnancy outcome from 121 
counties/districts of 21 cities in Guangdong Province, 
China. The study design, organization and implemen-
tation have been described previously15 (online supple-
mental appendix 1). The study was executed jointly by 
Guangzhou Medical University and Guangdong Institute 
of Family Planning Science and Technology, in which the 
review boards determined that this study was exempt for 
ethical approval owing to the use of de- identified data.
In the current analysis, women were eligible for inclu-
sion if they measured fasting serum glucose (FSG) and 
weight and height before pregnancy. Because chronic 
diseases have a known impact on adverse pregnancy 
outcomes and are prone to take interventions before 
conception and during the pregnancy, women with self- 
reported anemia, hypertension, diabetes, heart disease, 
hepatitis B, epilepsy, thyroid disease, chronic nephritis 
and cancer were excluded; women with newly identified 
hypertension (systolic blood pressure ≥140 mm Hg or 
diastolic blood pressure ≥90 mm Hg) and newly identified 
diabetes (FSG≥7.0 mmol/L) were also excluded. We also 
excluded women with multiple births or post- term preg-
nancies (gestation age >42 weeks), and with outcomes 
of miscarriages, induced abortions, birth defects or still-
births, as there are either no criteria to define LGA, or 
gestational age or birth weight is unavailable for these 
neonates.16
Exposure
BMI was calculated by dividing the weight in kilograms by 
the square of the height in meters and was classified into 
four categories based on the Chinese criteria17: under-
weight (BMI <18.5 kg/m2), normal weight (18.5–23.9 kg/
m2), overweight (24.0–27.9 kg/m2) and obesity (≥28.0 kg/
m2). Based on WHO guidelines,18 IFG was defined as 
FSG concentration of 6.1 mmol/L or greater and lower 
than 7.0 mmol/L.11 Normoglycemia was defined as FSG 
concentration lower than 6.1 mmol/L. All the partici-
pants included were categorized into eight groups based 
on FSG categories and BMI categories.
Outcomes
The primary outcomes were PTB, early PTB, LGA and 
severe LGA. PTB was defined as births delivered at gesta-
tional age less than 37 weeks and early PTB as births deliv-
ered at gestational age less than 34 weeks. Gestational 
age was measured by ultrasound at the first trimester of 
pregnancy. Based on the international standards in the 
INTERGROWTH- 21st Project,19 LGA was defined as 
birth weight by gestational age and gender beyond the 
90th percentile, and severe LGA as birth weight by gesta-
tional age and gender beyond the 97th percentile.
Statistical analysis
Mean and SD were reported for continuous variables, 
and frequencies and percentage were reported for cate-
gorical variables. Statistical interactions between BMI 
(four categories) and maternal pre- pregnancy IFG (yes 
or no) on PTB, early PTB, LGA and severe LGA were 
assessed. As our data covered over the 4 -year period, in 
which there was a possibility that women with more than 
one pregnancy have been included, we employed log- 
binomial models with generalized estimating equations 
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to estimate the adjusted incidence risk ratios (aIRRs) 
and 95% CIs of PTB, early PTB, LGA and severe LGA for 
women with different status of IFG and BMI. The refer-
ence group was normal weight with normoglycemia. In 
each outcome, three models were fitted.
In model 1, we adjusted for participants’ sociode-
mographic characteristics, including age at baseline, 
ethnicity, educational level, occupation, region and 
migrant population. In model 2, we additionally adjusted 
for history of pregnancy and history of adverse pregnancy 
outcomes, including first pregnancy (primipara), history 
of PTB, miscarriage, induced abortion, birth defects or 
stillbirth. In model 3, we additionally adjusted for the life-
styles of the women and the husband, including smoking 
status of husband before pregnancy and during the early 
stage of pregnancy, smoking and alcohol consumption of 
women before pregnancy and during the early stage of 
pregnancy, and passive smoking of women before preg-
nancy. Because infant’s sex is associated with PTB and 
early PTB, we also adjusted for this variable in all analysis 
of PTB and early PTB in addition to others listed (online 
supplemental table 1).20
Stratified analysis was undertaken according to 
maternal age to explore potential disparities in the asso-
ciation of BMI and FSG with LGA and PTB. Because the 
number of women aged 35–39 years and 40–50 years 
were relatively small, we merged these two groups into 
one group in stratified analysis. In addition, we adjusted 
for the length of time from pre- pregnancy examination 
to the last menstrual period (continuous data) or the 
year participated NFPHEP (five categories) to examine 
the robustness of the association of IFG and BMI with the 
four outcomes.
Missing covariates were inputted by using the mono-
tone logistic regression method based on other sociode-
mographic covariates by creating 50 imputed data sets.21 
The significance level was set at 0.05 and all tests were two 




The selection of participants for this study is shown in 
online supplemental figure 1. After excluding women who 
had chronic diseases, and who had miscarriage, induced 
abortion, stillbirth or birth defect and had multiple 
births or post- term pregnancy, the analytic sample size 
comprised 634,030 participants. In total, 44.2% of the 
participants were from nine cities in the Pearl River Delta 
and 10.2% were migrant populations. The sample size 
and the proportion of the migrant population in each 
city are shown in online supplemental table 2. The age of 
the participants included in the study ranged from 19 to 
50 years, the median age was 26 years (IQR 24–29) and 
6.1% of the women were older than 35 years. In addition, 
99.3% of the participants were Han ethnicity. Maternal 
characteristics with respect to pre- pregnancy status of 
FSG and BMI are shown in online supplemental table 3.
Associations of IFG and BMI with LGA and severe LGA
The median length of time from pre- pregnancy exam-
ination to the last menstrual period was 3.1 months 
(IQR 1.7–5.2). Among 630,430 included singleton 
births, 44,901 births were LGA, and the LGA rate was 
7.12% (95% CI 7.06% to 7.18%), ranging from 5.74% 
in underweight women with normoglycemia to 14.18% 
in obese women with IFG. Moreover, 15,936 births were 
severe LGA, and the severe LGA rate was 2.53% (2.49% 
to 2.57%), ranging from 2.07% in underweight women 
with normoglycemia to 5.82% in obese women with IFG 
(table 1). Statistically significant interactions were found 
between maternal pre- pregnancy IFG and BMI on both 
LGA (χ2=769.72, p<0.001) and severe LGA (χ2=301.20, 
p<0.001). In the fully adjusted model (model 3), for 
mothers with pre- pregnancy normoglycemia or IFG, the 
aIRRs for both LGA and severe LGA increased gradually 
as maternal BMI increased. For example, mothers who 
were obese with normoglycemia had 26.0% higher risk of 
LGA (aIRR 1.26; 95% CI 1.19 to 1.33) and 44.0% higher 
risk of severe LGA (1.44; 1.31 to 1.58). Obesity plus IFG 
had the highest risk of LGA (1.85; 1.60 to 2.14) and 
severe LGA (2.19; 1.73 to 2.79). In addition, underweight 
mothers with normoglycemia had a markedly lower risk 
of LGA (0.83; 0.81 to 0.85) and severe LGA (0.85; 0.81 
to 0.89).
Associations of IFG and BMI with PTB and early PTB
Among 630,430 included singleton births, 32,294 were 
PTB, and the PTB rate was 5.09% (5.04% to 5.14%), 
ranging from 5.01% in normal weight women with 
normoglycemia to 7.55% in obese women with IFG. In 
addition, 7123 of 634,030 births were early PTB, and the 
early PTB rate was 1.12% (1.09% to 1.15%), ranging from 
0.92% in overweight women with IFG to 1.31% in obese 
women with normoglycemia (table 2). Statistically signifi-
cant interactions were found between pre- pregnancy IFG 
and BMI on PTB (χ2=36.16, p<0.001) but not on early 
PTB (χ2=13.16, p=0.068). The aIRRs for PTB and early 
PTB according to pre- pregnancy status of IFG and BMI 
are shown in table 2. In the fully adjusted model (model 
3), compared with normal weight mothers with normo-
glycemia, underweight mothers with normoglycemia had 
6.0% higher risk of PTB (1.06; 1.03 to 1.09) and 8.0% 
higher risk of early PTB (1.08; 1.02 to 1.17); underweight 
mothers with IFG had 14.0% higher risk of PTB (1.14; 
1.02 to 1.27); and obese mothers with IFG had the highest 
risk of PTB (1.45; 1.18 to 1.78). In all the three models of 
PTB, early PTB, LGA and severe LGA, the aIRRs did not 
substantially change.
Associations of IFG and BMI with LGA and PTB according to 
maternal age
The associations of pre- pregnancy FSG and BMI with 
LGA were similarly observed among all the age groups 
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(figure 1). Obesity and overweight with normoglycemia 
or IFG were associated with increased risk of LGA among 
all the age groups, except for overweight with normogly-
cemia or IFG among mothers aged 19–24 years, while 
underweight with normoglycemia was inversely associ-
ated with LGA among all age groups.
The associations of pre- pregnancy FSG and BMI with 
PTB differed by maternal age (figure 2). Stratified analysis 
showed that underweight with normoglycemia was associ-
ated with increased risk of PTB among mothers younger 
than 30 years, and underweight with IFG was associated 
with increased risk of PTB among mothers aged 19–24 
years (1.24; 1.05 to 1.45). Obesity with normoglycemia 
was associated with increased risk of PTB among mothers 
aged 25–29 years (1.14; 1.01 to 1.28), and obesity with 
IFG was associated with increased risk of PTB among 
mothers younger than 30 years. Overweight with normo-
glycemia was only associated with increased risk of PTB 
among mothers aged older than 35 years (1.14; 1.03 to 
1.26).
Sensitivity analyses
In the sensitivity analyses, the association of pre- 
pregnancy FSG and BMI with the four outcomes did not 
substantially change with additional adjustment for the 
length of time from pre- pregnancy examination to last 
menstrual period or inclusion of the year participated 
NFPHEP (online supplemental table 4).
DISCUSSION
To our knowledge, this is the first study to investigate the 
associations for pre- pregnancy IFG, stratified by maternal 
BMI, with the risks of LGA and PTB. In this large cohort 
study conducted in China, with effect estimates for 5 
years, we provide evidence of markedly increased risks 
for LGA and severe LGA after exposure to overweight 
Table 1 aRRs for LGA and severe LGA according to pre- pregnancy status of FSG and BMI
  Events
Model 1* Model 2† Model 3‡
IRR (95% CI) P value IRR (95% CI) P value IRR (95% CI) P value
Large for gestational age
  Group 1 (N=124,288) 7128 (5.74%) 0.83 (0.81 to 0.85) <0.001 0.83 (0.81 to 0.85) <0.001 0.83 (0.81 to 0.86) <0.001
  Group 2 (N=405,190) 28 928 (7.14%) 1.00 (reference) … 1.00 (reference) … 1.00 (reference) …
  Group 3 (N=61,389) 5242 (8.54%) 1.16 (1.13 to 1.19) <0.001 1.15 (1.11 to 1.18) <0.001 1.14 (1.11 to 1.17) <0.001
  Group 4 (N=12,395) 1171 (9.45%) 1.28 (1.21 to 1.35) <0.001 1.27 (1.20 to 1.34) <0.001 1.26 (1.19 to 1.33) <0.001
  Group 5 (N=5515) 368 (6.67%) 0.97 (0.88 to 1.08) 0.614 0.97 (0.88 to 1.08) 0.612 0.96 (0.87 to 1.07) 0.478
  Group 6 (N=19,824) 1478 (7.46%) 1.04 (0.99 to 1.09) 0.159 1.04 (0.99 to 1.10) 0.094 1.04 (0.99 to 1.09) 0.115
  Group 7 (N=4329) 430 (9.93%) 1.33 (1.22 to 1.46) <0.001 1.33 (1.22 to 1.46) <0.001 1.32 (1.20 to 1.44) <0.001
  Group 8 (N=1100) 156 
(14.18%)
1.88 (1.62 to 2.17) <0.001 1.87 (1.62 to 2.17) <0.001 1.85 (1.60 to 2.14) <0.001
Severe large for gestational age
  Group 1 (N=124,288) 2575 (2.07%) 0.85 (0.81 to 0.89) <0.001 0.85 (0.81 to 0.89) <0.001 0.85 (0.81 to 0.89) <0.001
  Group 2 (N=405,190) 10 142 (2.50) 1.00 (reference) … 1.00 (reference) … 1.00 (reference) …
  Group 3 (N=61,389) 1834 (2.99%) 1.16 (1.11 to 1.22) <0.001 1.16 (1.11 to 1.22) <0.001 1.16 (1.10 to 1.22) <0.001
  Group 4 (N=12,395) 463 (3.74%) 1.45 (1.32 to 1.59) <0.001 1.45 (1.32 to 1.59) <0.001 1.44 (1.31 to 1.58) <0.001
  Group 5 (N=5515) 123 (2.23%) 0.91 (0.76 to 1.09) 0.303 0.91 (0.77 to 1.09) 0.316 0.91 (0.77 to 1.09) 0.311
  Group 6 (N=19,824) 565 (2.85%) 1.13 (1.04 to 1.23) 0.004 1.13 (1.04 to 1.23) 0.004 1.13 (1.04 to 1.23) 0.004
  Group 7 (N=4329) 170 (3.93%) 1.53 (1.31 to 1.77) <0.001 1.52 (1.31 to 1.77) <0.001 1.51 (1.30 to 1.75) <0.001
  Group 8 (N=1100) 64 (5.82%) 2.23 (1.76 to 2.84) <0.001 2.23 (1.76 to 2.83) <0.001 2.19 (1.73 to 2.79) <0.001
Pre- pregnancy status of FSG and BMI are defined as follows: group 1, underweight (BMI<18.5) plus normoglycemia (FSG<6.1 mmol/L); 
group 2, normal weight (18.5–24.0) plus normoglycemia; group 3, overweight (27.9≥BMI≥24) plus normoglycemia; group 4, obesity 
(BMI≥28) plus normoglycemia; group 5, underweight plus IFG (7.0 mmol/L>FSG≥6.1 mmol/L); group 6, normal weight plus IFG; group 7, 
overweight plus IFG; group 8, obesity plus IFG.
*Model 1: risk ratios were adjusted for sociodemographic characteristics of maternal (age, education level, occupation, ethnicity, region 
and migrant population).
†Model 2: risk ratios were additionally adjusted for history of pregnancy (first gestation and primipara) and history of adverse pregnancy 
outcomes (preterm birth, miscarriage, induced abortion, birth defect and stillbirth).
‡Model 3: risk ratios were adjusted for pre- pregnancy body mass index, active smoking, passive smoking, husband smoking and 
alcohol consumption status of maternal before pregnancy and active smoking, husband smoking, alcohol drinking status during early 
stage of pregnancy, in addition to the covariates in model 2.
aRR, adjusted risk ratio; BMI, body mass index; FSG, fasting serum glucose; IFG, impaired fasting glucose; IRR, incidence risk ratio; 
LGA, large for gestational age.
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or obesity with normoglycemia, and the risks were much 
higher for mothers who were overweight and obese with 
IFG; however, underweight with normoglycemia was 
inversely associated with the risks of LGA and severe 
LGA. The associations of IFG and BMI with LGA were 
similar among women of all age groups. In addition, risk 
of PTB was increased for underweight mothers regard-
less of IFG, and obese mothers with IFG had the highest 
risk of PTB. However, the associations of IFG and BMI 
with PTB differed according to maternal age.
In the context of pregnancy, insulin resistance is a 
critical normal pathophysiologic mechanism to ensure 
adequate energy supply for the growing fetus.22 However, 
among women with obesity, metabolic syndrome, and 
women with hyperglycemia or diabetes, the increasing 
insulin resistance demands of normal pregnancy place 
further burden on the maternal β cell to step up secre-
tion. Unmet to this demand leads to excess glucose, lipid 
and amino acid exposure to the fetal- placental unit.23 
This often leads to hyperinsulinemia that enhances fetal 
growth and an overabundance of maternal substrate for 
excess fetal fat accretion.24 In this study, we found the risk 
of LGA and severe LGA were much higher for overweight/
obese mothers with pre- pregnancy IFG than overweight/
obese mothers without IFG, probably because both 
obesity/overweight and pre- pregnancy IFG are associated 
with hyperglycemia and insulin resistance,25 26 leading 
to increased placental energy transfer and secretion of 
insulin in combination with an excess of triglyceride, 
leptin and adiponectin.27 It is noted that although IFG 
and BMI are interrelated, their associations with LGA or 
severe LGA are partially independent, and obesity/over-
weight alone accounts for more risk of LGA and severe 
LGA than pregnancies complicated by pre- pregnancy IFG 
alone.26 27 The associations of pre- pregnancy IFG and BMI 
with LGA were similar among all age groups, suggesting 
that the underlying mechanisms causing LGA are similar 
by age, and implied that weight loss or glucose control 
before pregnancy might be a preventive measure against 
LGA among obese/overweight or/and IFG women.
Table 2 aRRs for PTB and early PTB according to pre- pregnancy status of FSG and BMI
  Events
Model 1* Model 2† Model 3‡
IRR (95% CI) P value IRR (95% CI) P value IRR (95% CI) P value
Preterm birth
  Group 1 (n=124,288) 6562 (5.28%) 1.07 (1.04 to 1.10) <0.001 1.06 (1.03 to 1.09) <0.001 1.06 (1.03 to 1.09) <0.001
  Group 2 (n=405,190) 20 284 (5.01%) 1.00 (reference) … 1.00 (reference) … 1.00 (reference) …
  Group 3 (n=61,389) 3107 (5.06%) 1.00 (0.97 to 1.04) 0.828 1.00 (0.97 to 1.04) 0.870 0.99 (0.95 to 1.03) 0.534
  Group 4 (n=12,395) 668 (5.39%) 1.06 (0.98 to 1.15) 0.110 1.06 (0.99 to 1.15) 0.108 1.04 (0.96 to 1.12) 0.254
  Group 5 (n=5515) 314 (5.69%) 1.16 (1.04 to 1.29) 0.008 1.14 (1.02 to 1.27) 0.016 1.14 (1.02 to 1.27) 0.018
  Group 6 (n=19,824) 1035 (5.22%) 1.04 (0.98 to 1.11) 0.159 1.04 (0.98 to 1.10) 0.236 1.04 (0.98 to 1.10) 0.249
  Group 7 (n=4329) 241 (5.57%) 1.10 (0.97 to 1.24) 0.148 1.08 (0.96 to 1.23) 0.196 1.09 (0.96 to 1.23) 0.182
  Group 8 (n=1100) 83 (7.55%) 1.46 (1.18 to 1.79) <0.001 1.45 (1.17 to 1.78) <0.001 1.45 (1.18 to 1.78) <0.001
Early preterm birth
  Group 1 (n=124,288) 1480 (1.19%) 1.09 (1.03 to 1.16) 0.004 1.08 (1.02 to 1.15) 0.008 1.08 (1.02 to 1.17) 0.010
  Group 2 (n=405,190) 4488 (1.11%) 1.00 (reference) … 1.00 (reference) … 1.00 (reference) …
  Group 3 (n=61,389) 674 (1.10%) 0.99 (0.91 to 1.07) 0.765 0.99 (0.91 to 1.07) 0.735 0.97 (0.90 to 1.06) 0.515
  Group 4 (n=12,395) 162 (1.31%) 1.17 (1.00 to 1.37) 0.051 1.17 (1.00 to 1.36) 0.053 1.15 (0.98 to 1.34) 0.080
  Group 5 (n=5515) 56 (1.02%) 0.94 (0.72 to 1.22) 0.616 0.92 (0.71 to 1.20) 0.557 0.92 (0.71 to 1.20) 0.539
  Group 6 (n=19,824) 209 (1.05%) 0.96 (0.83 to 1.10) 0.547 0.95 (0.83 to 1.09) 0.494 0.95 (0.83 to 1.09) 0.464
  Group 7 (n=4329) 40 (0.92%) 0.83 (0.61 to 1.13) 0.239 0.83 (0.61 to 1.13) 0.228 0.82 (0.60 to 1.12) 0.211
  Group 8 (n=1100) 14 (1.27%) 1.11 (0.66 to 1.87) 0.690 1.12 (0.66 to 1.89) 0.670 1.12 (0.66 to 1.88) 0.678
Pre- pregnancy status of FSG and BMI are defined as follows: group 1, underweight (BMI<18.5) plus normoglycemia (FSG<6.1 mmol/L); 
group 2, normal weight (18.5–24.0) plus normoglycemia; group 3, overweight (27.9≥BMI≥24) plus normoglycemia; group 4, obesity 
(BMI≥28) plus normoglycemia; group 5, underweight plus IFG (7.0 mmol/L>FSG≥6.1 mmol/L); group 6, normal weight plus IFG; group 7, 
overweight plus IFG; group 8, obesity plus IFG.
*Model 1: risk ratios were adjusted for sociodemographic characteristics of maternal (age, education level, occupation, ethnicity, region 
and migrant population) and infants’ sex.
†Model 2: risk ratios were additionally adjusted for history of pregnancy (first gestation and primipara) and history of adverse pregnancy 
outcomes (preterm birth, miscarriage, induced abortion, birth defect and stillbirth).
‡Model 3: risk ratios were adjusted for pre- pregnancy body mass index, active smoking, passive smoking, husband smoking and 
alcohol consumption status of maternal before pregnancy and active smoking, husband smoking, alcohol drinking status during early 
stage of pregnancy, in addition to the covariates in model 2.
aRR, adjusted risk ratio; BMI, body mass index; FSG, fasting serum glucose; IFG, impaired fasting glucose; IRR, incidence risk ratio; 
PTB, preterm birth.
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Findings from our study suggested markedly higher 
risk of PTB among underweight women regardless of 
IFG and among obese women with IFG, but no signif-
icant higher risk of PTB among obese women with 
normoglycemia, which were consistent with some 
studies conducted in low- income and middle- income 
countries,28 but inconsistent with studies conducted 
in developed countries.29 30 The discrepancy might 
be related to the different characteristics of the study 
population, for example, obese women in developed 
countries are prone to be hyperglycemia.28–30 In addi-
tion, although previous studies demonstrated that pre- 
pregnancy IFG had a higher risk of PTB,11 31 we did not 
find significant associations between normal weight/
overweight with IFG and PTB, which may imply that 
risk of PTB among IFG mothers mainly derived from 
underweight and obesity.
Our findings showed that the associations of pre- 
pregnancy IFG and BMI with PTB differed by maternal 
age, which is similar to a previous study.29 In women 
aged 20 years or older, maternal overweight/obesity 
and IFG could increase the risk of gestational diabetes 
and pre- eclampsia, which might subsequently increase 
the risk of PTB.32 However, in China, women older than 
30 years are more likely to be multipara (online supple-
mental table 5), who might have knowledge, experi-
ences and skills against PTB.20 The risk of PTB differed 
by maternal age highlights that specific tailored recom-
mendations for pregnancy according to maternal age 
are urgently needed to accurately stratify the risk of 
PTB, although more work is needed.29
Strengths and limitations
The major strength of this study is the sample size. For 
this cohort, we recruited more than 634,000 women 
and followed up pregnancy outcomes with strict quality 
controls. The number of each exposure category and 
events per baseline variables were enough that the multi-
variable regression models were not over- fitted. The large 
sample size also allowed us to assess the effect of maternal 
age on the associations of pre- pregnancy IFG and BMI 
with LGA and PTB. The measurement of the exposures 
is the other major strength of the study that minimizes 
exposure misclassification—BMI was measured by cali-
brated instruments and IFG was measured by a fasting 
blood glucose test. Ascertaining these exposures prior 
to pregnancy is also a strength as compared with many 
studies that obtained pre- pregnancy weight from self- 
reports during pregnancy.33
The study has some limitations. First, we cannot iden-
tify whether the associations of pre- pregnancy IFG and 
BMI with LGA and PTB were modified by pregnancy 
complications (pre- eclampsia and gestational diabetes) 
because most of the participants (99.1%) did not test 
Figure 1 Association of IFG and BMI with risk of LGA by maternal age group. Pre- pregnancy status of FSG and BMI 
are defined as follows: group 1, underweight (BMI <18.5) plus normoglycemia (FSG <6.1 mmol/L); group 2, normal weight 
(18.5–24.0) plus normoglycemia; group 3, overweight (27.9≥BMI≥24) plus normoglycemia; group 4, obesity (BMI ≥28) plus 
normoglycemia; group 5, underweight plus IFG (7.0 mmol/L>FSG≥6.1 mmol/L); group 6, normal weight plus IFG; group 7, 
overweight plus IFG; group 8, obesity plus IFG. aIRR, adjusted incidence risk ratio; BMI, body mass index; FSG, fasting serum 
glucose; IFG, impaired fasting glucose; LGA, large for gestational age.
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for gestational diabetes and pre- eclampsia. Women 
with pregnancy complications may lead to overestimate 
the effect of BMI and pre- pregnancy IFG on LGA and 
PTB, while women who have controlled the glucose level 
through lifestyle change may lead to underestimate the 
effect of pre- pregnancy IFG and BMI on the outcomes. 
Second, the NFPHEP did not collect data on the reason 
for each case of PTB, which precludes us from doing 
analyses for each subtype of PTB. Third, maternal BMI is 
only measured before pregnancy, thus we cannot adjust 
for weight gain in the analysis, although previous study 
suggested that weight gain did not substantially affect 
the association of pregnancy BMI with PTB.15 Third, 
we excluded women with pre- existing chronic diseases, 
including anemia, hypertension, diabetes, heart disease, 
hepatitis B, epilepsy, thyroid disease, chronic nephritis 
and cancer from our analysis, and thus our findings 
cannot be generalized to these populations, although 
these chronic diseases have a known impact on adverse 
pregnancy outcomes. Fourth, the study population have a 
higher rate of underweight and lower rate of obesity than 
that in western countries, which may limit the generaliz-
ability of our findings. Finally, although we have adjusted 
for many potential confounders, we cannot rule out the 
possibility of residual confounding by unknown factors.
CONCLUSION
In conclusion, in this large retrospective cohort study, 
pre- pregnancy overweight/obesity was associated with 
increased risk of LGA regardless of the pre- pregnancy 
IFG, and the associations were similar observed among 
mothers of all age groups. Pre- pregnancy underweight 
regardless of IFG was associated with increased risk of 
PTB, and the risk of PTB was highest among mothers who 
were obese with IFG. However, the associations of IFG 
Figure 2 Association of IFG and BMI with risk of PTB by maternal age group. Pre- pregnancy status of FSG and BMI 
are defined as follows: group 1, underweight (BMI <18.5) plus normoglycemia (FSG <6.1 mmol/L); group 2, normal weight 
(18.5–24.0) plus normoglycemia; group 3, overweight (27.9≥BMI≥24) plus normoglycemia; group 4, obesity (BMI ≥28) plus 
normoglycemia; group 5, underweight plus IFG (7.0 mmol/L>FSG≥6.1 mmol/L); group 6, normal weight plus IFG; group 7, 
overweight plus IFG; group 8, obesity plus IFG. aIRR, adjusted incidence risk ratio; BMI, body mass index; FSG, fasting serum 
glucose; IFG, impaired fasting glucose; PTB, preterm birth.
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and BMI with PTB differed by maternal age. These find-
ings may have implications for future risk assessment and 
counseling to prevent adverse birth outcomes, although 
these findings need to be validated in a different popu-
lation. These findings may also suggest that keeping 
normal BMI and normoglycemia before pregnancy may 
reduce the risk of LGA and PTB.
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